Patent · US Active

Methods of treating mitochondrial dysfunction

US10709724B2 · kind B2 · utility

5Cited by
1References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 16, 2018
Grant dateJul 14, 2020
Priority date
Expiry dateMar 16, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods of treating various disorders associated with mitochondrial dysfunction, including but not limited to metabolic disorders, neurodegenerative diseases, chronic inflammatory diseases, and diseases of aging.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.